# Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy

> **NCT00041795** · PHASE2 · COMPLETED · sponsor: **NeoTherapeutics** · enrollment: 50 (—)

## Conditions studied

- Peripheral Nervous System Diseases
- Chemotherapy-Induced Peripheral Neuropathy

## Interventions

- **DRUG:** leteprinim potassium (Neotrofin)

## Key facts

- **NCT ID:** NCT00041795
- **Lead sponsor:** NeoTherapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 50 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00041795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00041795, "Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00041795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*